A promising new HIV treatment called pirmitegravir has shown encouraging early results in human clinical trials. Researchers presented the findings at the IDWeek 2025 medical conference. Pirmitegravir belongs to a brand-new class of HIV medicines called allosteric integrase inhibitors. Unlike current HIV drugs that target the virus in familiar ways, Read more…
New national guidelines for anal cancer prevention in HIV patients based on UCSF research. Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce Read more…
June 27 is National HIV Testing Day The only way to know your HIV status is to get tested. Knowing your status gives you powerful information to keep you and your partner healthy. CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least Read more…
Golden Rule Services’ new mobile testing unit and GRS founder, Clarmundo Sullivan, was recently featured on KCRA 3 news. The purpose of this mobile testing unit is to provide HIV, STD, and COVID-19 testing for underserved communities. Check out the feature below!
The U.S. Food and Drug Administration approved Cabenuva as a complete regimen for the treatment of HIV-1 infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance Read more…
About one-third of people prescribed drugs to prevent HIV stopped taking the medications when they were forced to stay home due to the coronavirus pandemic, a new survey finds. The reason, they said: They weren’t having sex. Many discontinued the drugs without their doctor’s say-so, which has experts concerned. Read Read more…